Inventor · disambiguated record
Qi Gao
Also filed as: GAO QI
20 granted patents·21 pending applications·54 citations·filing 1992–2024
92Inventor score
Files withBRISTOL MYERS SQUIBB CO14SPH XING LING SCI & TECH PHARMACEUTICAL CO LTD5BEIJING GLYEXO GENE TECH CO LTD2DOW GLOBAL TECHNOLOGIES LLC2PLIANT THERAPEUTICS INC2
Top patents by PatentIndex Score
41 records- 0195US12018025B2Integrin inhibitor and uses thereofPLIANT THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·2 cites·163 claims
- 0290US7851476B2Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazineBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 14, 2010·16 cites·14 claims
- 0387US8445494B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineQIU JUN·Filed 2009·Granted May 21, 2013·11 cites·1 claims
- 0482US9156812B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 13, 2015·3 cites·7 claims
- 0582US7723338B2Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazineBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 25, 2010·5 cites·12 claims
- 0680US8629171B2Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride saltKIM SOOJIN·Filed 2008·Granted Jan 14, 2014·5 cites·25 claims
- 0776US7601715B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 13, 2009·4 cites·12 claims
- 0873US6475534B2Ginkgo biloba composition, method to prepare the same and uses thereofSHANGHAI XINGLING SCI & TECH P·Filed 2001·Granted Nov 5, 2002·6 cites·4 claims
- 0967US7829711B2Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dioneBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 9, 2010·0 cites·6 claims
- 1067US2024391914A1Integrin inhibitor and uses thereofPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1165US2010158862A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 1264US2025082703A1Ginkgo biloba ketone ester capsule and preparation method thereofSPH XING LING SCI & TECH PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1363US2024270719A1Crystalline forms of 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrileMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1462US2025340763A1Thermally detachable multilayer compositions bonded with thermo-plastic primersDOW GLOBAL TECHNOLOGIES LLC·Filed 2022·Application pending·0 cites
- 1560US2025202002A1Thermally triggered primer and thermosetting adhesive multilayer composition for detachment of ev battery packDOW GLOBAL TECHNOLOGIES LLC·Filed 2022·Application pending·0 cites
- 1658US9173879B2Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereofBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 3, 2015·0 cites·14 claims
- 1758US7968718B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jun 28, 2011·0 cites·1 claims
- 1856US9498476B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Nov 22, 2016·0 cites·2 claims
- 1955US6632460B2Ginkgo biloba composition, method to prepare the same and uses thereofSHANGHAI XINGLING SCI & TECH P·Filed 2002·Granted Oct 14, 2003·0 cites·16 claims
- 2055US2023021840A1Use of gp73 inhibitor in preparation of medicine for treating diabetesBEIJING SUNGEN BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 2154US2022372173A1Lectin-magnetic carrier coupling complex for separating glycosylated exosomes from clinical sampleBEIJING GLYEXO GENE TECH CO LTD·Filed 2022·Application pending·0 cites
- 2253US2022349901A1Lectin-macromolecule carrier coupling complex for separating glycosylated exosome in clinical sampleBEIJING GLYEXO GENE TECH CO LTD·Filed 2022·Application pending·0 cites
- 2353US2006100432A1Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneMATISKELLA JOHN D·Filed 2005·Application pending·0 cites
- 2452US2024294521A1Crystalline forms, compositions containing same, and methods of their useREPARE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2551US12390503B2Ginkgo biloba leave extract capsule and preparation method thereforSPH XING LING SCI & TECH PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 19, 2025·0 cites·5 claims
- 2651US2023118152A1Forms of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Application pending·0 cites
- 2750US2023212272A1Isolated antigen binding protein and use thereofLONGBIO PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 2850US2010292246A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2948US2006100209A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneGU CHONG-HUI·Filed 2005·Application pending·0 cites
- 3046US2011268697A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 3145US2023159582A1Crystalline forms of squalamineENTERIN INC·Filed 2020·Application pending·0 cites
- 3243US9518058B2Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 13, 2016·0 cites·9 claims
- 3342US5284866A1H-cycloundeca[1,2-b:5,6-b']biscyclohepta(b)pyrans useful as antitumor agentsBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Feb 8, 1994·2 cites·3 claims
- 3442US2022315571A1Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamideCYTOKINETICS INC·Filed 2020·Application pending·0 cites
- 3540US2008254155A1Use of Ginkgo Biloba Extract in Preparation of a Composition for Lowering CholesterolSHANGHAI BIOCHIP CO LTD·Filed 2006·Application pending·0 cites
- 3639US12311002B2Extract of Ginkgo biloba leaves and preparation method thereforSPH XING LING SCI & TECH PHARMACEUTICAL CO LTD·Filed 2018·Granted May 27, 2025·0 cites·4 claims
- 3739US11440930B2Preparation method of high-purity total ginkgo flavonol glycoside and application of sameSPH XING LING SCI & TECH PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 13, 2022·0 cites·7 claims
- 3839US8815894B2Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereofWEI CHENKOU·Filed 2010·Granted Aug 26, 2014·0 cites·16 claims
- 3938US2006264406A1Mono-lysine salts of azole compoundsEISAI CO LTD·Filed 2006·Application pending·0 cites
- 4031US5622863ACulture of Eupenicillium brefeldianumBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Apr 22, 1997·0 cites·1 claims
- 4131US2021188866A1Method for preparing high-purity total ginkgolide and use thereofSPH XING LING SCI & TECH PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qi Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →